Freeline Therapeutics Holdings plc Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q1 2022 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Freeline Therapeutics Holdings plc quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q1 2022 to Q3 2023.
  • Freeline Therapeutics Holdings plc Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending September 30, 2023 was $383K, a 92.8% decline year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $383K -$4.93M -92.8% Sep 30, 2023 6-K 2023-12-01
Q2 2023 $481K -$18.5M -97.5% Jun 30, 2023 6-K 2023-08-15
Q1 2023 $570K -$21.3M -97.4% Mar 31, 2023 6-K 2023-05-30
Q4 2022 $5.97M Dec 31, 2022 20-F 2023-04-04
Q3 2022 $5.32M Sep 30, 2022 6-K 2022-11-15
Q2 2022 $18.9M Jun 30, 2022 6-K 2022-08-09
Q1 2022 $21.9M Mar 31, 2022 6-K 2022-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.